From: ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
Analysis: | DMFS ≤5 years Censor vs. Event | ||
---|---|---|---|
Treatment: | TAM | TAM | TAM+ |
Patient #: | 95 vs. 68 | 3 vs. 11 | 17 vs 7 |
Gene | Loi | Zhang | Zhou |
ACADM | up | ||
AHSA1 | up | up | |
ARIH2 | up | ||
ATP5C1 | up | ||
ATP5F1 | up | ||
CENPT | up | ||
CSMD1 | down | ||
DLST | up | ||
EEF1A2 | up | ||
ETFB | up | ||
GTPBP4 | up | ||
HSPA9 | up | ||
IDH1 | up | ||
MED23 | up | ||
MYCN | down | ||
NADK | up | up | |
NDUFA8 | up | ||
NDUFB5 | up | ||
NDUFS1 | up | ||
NDUFS7 | up | ||
ORMDL1 | up | ||
PAN2 | up | ||
PCMTD2 | up | ||
PPIF | up | ||
PTCD3 | up | ||
PTPN18 | down | ||
RAB11B | down | ||
RAB21 | up | up | |
RARA | down | ||
SDHD | up | ||
SLC35E2 | up | ||
SPTLC2 | up | ||
SUCLA2 | up | ||
TIMM17A | up | ||
TRRAP | up | ||
TSPAN8 | up | ||
UNC50 | up |